{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:33:45Z","timestamp":1791855225321,"version":"4.3.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,10]],"date-time":"2019-11-10T00:00:00Z","timestamp":1573344000000},"content-version":"vor","delay-in-days":1623,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1093\/annonc\/mdv129","type":"journal-article","created":{"date-parts":[[2015,3,10]],"date-time":"2015-03-10T00:02:13Z","timestamp":1425945733000},"page":"1244-1248","source":"Crossref","is-referenced-by-count":59,"title":["The impact of docetaxel-related toxicities on health-related quality of life in patients with metastatic cancer (QoliTax)"],"prefix":"10.1016","volume":"26","author":[{"given":"S.-E.","family":"Al-Batran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Hozaeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.K.","family":"Tauchert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.-D.","family":"Hofheinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Windemuth-Kieselbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"H\u00fcbner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Burmester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Koenigsmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Wiegand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"zur Hausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Linsse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Kuhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Pauligk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdv129_bb0010","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1200\/JCO.2010.33.4631","article-title":"Relationship between deficits in overall quality of life and non-small-cell lung cancer survival","volume":"30","author":"Sloan","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv129_bb0015","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1200\/JCO.2007.13.3439","article-title":"The prognostic significance of patient-reported outcomes in cancer clinical trials","volume":"26","author":"Gotay","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv129_bb0020","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S1470-2045(09)70200-1","article-title":"Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials","volume":"10","author":"Quinten","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdv129_bb0025","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1002\/cncr.25064","article-title":"Impact of chemotherapy on quality of life in patients with metastatic esophagogastric cancer","volume":"116","author":"Al-Batran","year":"2010","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdv129_bb0030","first-page":"371","article-title":"Update on taxane development: new analogs and new formulations","volume":"6","author":"Yared","year":"2012","journal-title":"Drug Des Devel Ther"},{"key":"10.1093\/annonc\/mdv129_bb0035","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1634\/theoncologist.9-5-538","article-title":"Practical aspects of weekly docetaxel administration schedules","volume":"9","author":"Hainsworth","year":"2004","journal-title":"Oncologist"},{"key":"10.1093\/annonc\/mdv129_bb0040","first-page":"432a","article-title":"Febrile neutropenia is associated with an increase in the incidence, duration, and severity of chemotherapy toxicities","volume":"98","author":"Glaspy","year":"2001","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdv129_bb0045","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s00520-004-0757-4","article-title":"Impact of chemotherapy-induced neutropenia on quality of life: a prospective pilot investigation","volume":"13","author":"Fortner","year":"2005","journal-title":"Support Care Cancer"},{"key":"10.1093\/annonc\/mdv129_bb0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00520-007-0270-7","article-title":"Measuring health-related quality of life and neutropenia-specific concerns among older adults undergoing chemotherapy: validation of the Functional Assessment of Cancer Therapy-Neutropenia (FACT-N)","volume":"16","author":"Wagner","year":"2008","journal-title":"Support Care Cancer"},{"key":"10.1093\/annonc\/mdv129_bb0055","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1472-6955-4-4","article-title":"Experiencing neutropenia: quality of life interviews with adult cancer patients","volume":"4","author":"Fortner","year":"2005","journal-title":"BMC Nurs"},{"key":"10.1093\/annonc\/mdv129_bb0060","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1634\/theoncologist.12-S1-4","article-title":"Cancer-related fatigue: the scale of the problem","volume":"12","author":"Hofman","year":"2007","journal-title":"Oncologist"},{"key":"10.1093\/annonc\/mdv129_bb0065","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00520-008-0422-4","article-title":"Frequency of side effects in outpatient cancer care and their influence on patient satisfaction\u2014a prospective survey using the PASQOC questionnaire","volume":"16","author":"Feyer","year":"2008","journal-title":"Support Care Cancer"},{"key":"10.1093\/annonc\/mdv129_bb0070","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1200\/JCO.2006.06.8429","article-title":"Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group","volume":"24","author":"Van Cutsem","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv129_bb0075","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jpainsymman.2006.10.012","article-title":"The relationship between cancer-related fatigue and patient satisfaction with quality of life in cancer","volume":"34","author":"Gupta","year":"2007","journal-title":"J Pain Symptom Manage"},{"key":"10.1093\/annonc\/mdv129_bb0080","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1477-7525-8-107","article-title":"Respiratory symptoms in adults are related to impaired quality of life, regardless of asthma and COPD: results from the European community respiratory health survey","volume":"8","author":"Aanerud","year":"2010","journal-title":"Health Qual Life Outcomes"},{"key":"10.1093\/annonc\/mdv129_bb0085","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001674","article-title":"Life event stress and chronic obstructive pulmonary disease (COPD): associations with mental well-being and quality of life in a population-based study","volume":"2","author":"Lu","year":"2012","journal-title":"BMJ Open"},{"key":"10.1093\/annonc\/mdv129_bb0090","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1477-7525-10-98","article-title":"Correlations between disease-specific and generic health status questionnaires in patients with advanced COPD: a one-year observational study","volume":"10","author":"Wilke","year":"2012","journal-title":"Health Qual Life Outcomes"},{"key":"10.1093\/annonc\/mdv129_bb0095","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1183\/09031936.00153712","article-title":"The impact of COPD on health status: findings from the BOLD study","volume":"42","author":"Janson","year":"2013","journal-title":"Eur Respir J"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419318046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419318046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/26\/6\/1244\/16699882\/mdv129.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T18:22:52Z","timestamp":1717784572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419318046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0923753419318046"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdv129","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}